ENCOMPASS HEALTH REHABILITATION INST — History
CCN 033028 | 3-year financial timeline | COVID resilience: 33/100
🛡️ Public data only — no PHI permitted on this instance.
$17M
Latest Revenue (FY2022)
-22.3%
Revenue CAGR (3yr)
10.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $28M | $30M | $17M | -42.7% | -22.3% |
| Operating Expenses | $25M | $26M | $15M | -40.4% | -22.3% |
| Operating Margin | 10.1% | 13.8% | 10.2% | -26.2% | +0.2% |
| Net Income | $3M | $4M | $2M | -57.7% | -22.2% |
| Licensed Beds | 80 | 80 | 80 | +0.0% | +0.0% |
| Total Patient Days | 20,454 | 21,326 | 11,681 | -45.2% | -24.4% |
| Medicare Day % | 47% | 46% | 46% | +1.6% | -1.2% |
| Medicaid Day % | 1% | 1% | 1% | -30.9% | -28.4% |
COVID Impact & Recovery
Resilience Score: 33/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -39.7% ($28M → $17M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-22.3%
This Hospital
+7.6%
State Avg
Latest Margin
10.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $11M | 10.2% |
| FY2024 (proj) | $6M | 10.2% |
| FY2025 (proj) | $0M | 10.2% |